Sanofi allergy drug safe enough for non-prescription use: FDA reviewers

WASHINGTON Mon Jul 29, 2013 8:52am EDT

Related Topics

WASHINGTON (Reuters) - Sanofi SA's allergy drug Nasacort AQ is safe enough to be sold over the counter, according to reviewers for the U.S. Food and Drug Administration.

The reviewers, whose opinions were posted on Monday on the FDA's website, said the nasal spray, which currently requires a prescription for use, "has a favorable risk-benefit profile" for use in an over-the-counter setting.

The documents were posted ahead of a meeting on Wednesday of an advisory committee to the FDA which will recommend whether or not the agency should approve the switch to over-the-counter use. The drug is used to treat hay fever and other respiratory allergies.

(Reporting by Toni Clarke in Washington; Editing by Gerald E. McCormick)


After wave of QE, onus shifts to leaders to boost economy

DAVOS, Switzerland - Central banks have done their best to rescue the world economy by printing money and politicians must now act fast to enact structural reforms and pro-investment policies to boost growth, central bankers said on Saturday.